sábado, 5 de febrero de 2022

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study - The Lancet Gastroenterology & Hepatology

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study - The Lancet Gastroenterology & Hepatology

No hay comentarios:

Publicar un comentario